Acyclovir for pneumonia patients with HSV-1 on breathing support
Treatments studied
Part of Infections, Lungs & breathing, Skin clinical trials.
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need a breathing machine (ventilator) or non-invasive breathing support.
- A test of your lung fluid has found the herpes simplex virus (HSV-1).
- You have pneumonia (from any cause, including community, hospital, or ventilator).
- You are not allergic to acyclovir or similar drugs.
- You are not pregnant or breastfeeding.
- You are not currently taking any antiviral medication for herpes (like acyclovir, valacyclovir, or similar).
- You have not had a solid organ or stem cell transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests an investigational medicine (given in increasing doses) for hospitalized people with pneumonia who need supplemental oxygen. It aims to see if the medicine is safe and potentially helps the pneumonia process in the early hospital period.
This study tests whether giving acyclovir early—before symptoms appear—can help patients on a breathing machine who have a herpes virus in their throat. It aims to see if treatment can prevent complications and improve recovery.
This study looks at whether a common virus (herpes simplex virus type 1) becomes active in patients with severe pneumonia in the ICU. Understanding this may help improve treatment and care.
This study compares acyclovir (an antiviral medicine) to placebo (inactive treatment) in adults with HSV-2 meningitis. It aims to see whether acyclovir helps people recover faster or better after this infection of the lining around the brain.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
This study checks how acyclovir behaves in the body when it’s given by mouth or through an IV to children receiving cancer care. It may help doctors better choose doses and monitor the medicine in kids who need prevention or treatment of certain viral infections.
Hear when a new Pneumonia, Viral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.